Microneedling device SkinPen Precision has been awarded a Class IIa CE Certification mark by the British Standards Institution (BSI).
Holding a Class IIa CE Certification means that the device conforms to the requirements in the Medical Devices Directive, as well as the Medical Devices Regulations.
Joe Proctor, president of Crown Aesthetics the owners of SkinPen manufacturer Bellus Medical, commented, “This new and expanded certification further validates SkinPen’s safety and usage claims in the EU. With SkinPen’s advanced microneedling technology, we continue to set a higher standard in patient care, and it firmly establishes the industry benchmark for safety. This essential certification allows us to continue offering best-in-class technology to our physician partners, and their patients and solidifies the company’s growing presence in the global market.”